Emerging technologies and new directions in drug abuse research
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Rockville, MD
1991
|
Schriftenreihe: | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series
112 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV005423366 | ||
003 | DE-604 | ||
005 | 20030310 | ||
007 | t| | ||
008 | 920703s1991 xx ad|| |||| 00||| engod | ||
020 | |a 0160358515 |9 0-16-035851-5 | ||
035 | |a (OCoLC)24861441 | ||
035 | |a (DE-599)BVBBV005423366 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-20 | ||
050 | 0 | |a RC566 | |
050 | 0 | |a RM315 | |
082 | 0 | |a 615/.78 |2 20 | |
084 | |a CW 6940 |0 (DE-625)19200: |2 rvk | ||
245 | 1 | 0 | |a Emerging technologies and new directions in drug abuse research |c eds.: Rao S. Rapaka ... |
264 | 1 | |a Rockville, MD |c 1991 | |
300 | |a VII, 335 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |v 112 | |
650 | 2 | |a Troubles liés à une substance | |
650 | 4 | |a Drug abuse |x Treatment |x Research |z United States | |
650 | 4 | |a Narcotics | |
650 | 4 | |a Opioids |x Receptors |x Research |z United States | |
650 | 4 | |a Psychopharmacology |x Technological innovations |z United States | |
650 | 4 | |a Psychotropic Drugs | |
650 | 4 | |a Receptors, Opioid | |
650 | 4 | |a Substance-Related Disorders |x therapy | |
650 | 4 | |a Technology, Pharmaceutical | |
650 | 0 | 7 | |a Pharmazeutische Analyse |0 (DE-588)4174139-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Molekulardesign |0 (DE-588)4265444-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Halluzinogen |0 (DE-588)4134941-6 |2 gnd |9 rswk-swf |
651 | 4 | |a USA | |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
689 | 0 | 0 | |a Halluzinogen |0 (DE-588)4134941-6 |D s |
689 | 0 | 1 | |a Pharmazeutische Analyse |0 (DE-588)4174139-0 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Halluzinogen |0 (DE-588)4134941-6 |D s |
689 | 1 | 1 | |a Molekulardesign |0 (DE-588)4265444-0 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Rapaka, Rao S. |e Sonstige |4 oth | |
830 | 0 | |a National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |v 112 |w (DE-604)BV001902214 |9 112 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003390873&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-003390873 |
Datensatz im Suchindex
_version_ | 1819656803123724288 |
---|---|
adam_text | EMERGING TECHNOLOGIES AND NEW DIRECTIONS IN DRUG ABUSE RESEARCH EDITORS:
RAO S. RAPAKA, PH.D. ALEXANDROS MAKRIYANNIS, PH.D. MICHAEL J. KUHAR,
PH.D. RESEARCH MONOGRAPH 112 1991 U.S. DEPARTMENT OF HEALTH AND HUMAN
SERVICES PUBLIC HEALTH SERVICE ALCOHOL, DRUG ABUSE, AND MENTAL, HEALTH
ADMINISTRATION NATIONAL INSTITUTE ON DRUG ABUSE 5600 FISHERS LANE
ROCKVILLE, MD 20857 CONTENTS PAGE FOREWORD III EMERGING TECHNOLOGIES AND
NEW DIRECTIONS IN DRUG ABUSE RESEARCH: AN OVERVIEW 1 RAO S. RAPAKA,
ALEXANDROS MAKRIYANNIS, AND MICHAEL J. KUHAR VORONOI BINDING SITE MODELS
7 GORDON M. CRIPPEN A MECHANISTIC BASIS FOR DESIGN OF SELECTIVE AGONISTS
FOR 5-HT RECEPTORS 21 ROMAN OSMAN AND HAREL WEIOSTEIN COMPUTER-AIDED
DRUG DESIGN FOR THE BENZODIAZEPINE RECEPTOR SITE 43 GILDA H. LOEW, HUGO
O. VILLAR, WAYMONDJUNG, AND M. FRANCES DAVIES 3D-SEARCHING: AN OVERVIEW
OF A NEW TECHNIQUE FOR COMPUTER-ASSISTED MOLECULAR DESIGN 62 ROBERT S.
PEARLMAN PROTEIN STRUCTURE DETERMINATION IN SOLUTION USING NUCLEAR
MAGNETIC RESONANCE SPECTROSCOPY ..78 ANGELA M. GRONENBORN AND G. MARLUS
CLORE COMBINED USE OF SOLID-STATE NUCLEAR MAGNETIC RESONANCE
SPECTROSCOPY, SMALL-ANGLE X-RAY DIFFRACTION, AND DIFFERENTIAL SCANNING
CALORIMETRY IN STUDIES OF CANNABINOID : MEMBRANE INTERACTIONS 106
ALEXANDROS MAKRIYANNIS, DE-PING YANG, AND THOMAS MAVROMOUSTAKOS
CHARACTERIZATION AND LOCALIZATION OF CANNABINOID RECEPTORS IN BRAIN: AN
IN VITRO TECHNIQUE USING SLIDE-MOUNTED TISSUE SECTIONS 129 MILES
HERKENHAM NEW DEVELOPMENTS IN RADIOTRACERS FOR POSITRON EMISSION
TOMOGRAPHY 146 JOANNA S. FOWLER AND ALFRED P. WOLF USE OF POSITRON
EMISSION TOMOGRAPHY TO STUDY COCAINE IN THE HUMAN BRAIN 168 NORA D.
VOLKOW, JOANNA S. FOWLER, AND ALFRED P. WOLF DEVELOPMENT OF OPIOID
PEPTIDE ANALOGS AS PHARMACOLOGIC TOOLS AND AS POTENTIAL DRUGS: CURRENT
STATUS AND FUTURE DIRECTIONS 180 PETER W.SCHILLER ~ CONFORMATIONAL
ANALYSIS OF OPIOID RECEPTOR-SELECTIVE PEPTIDES USING NUCLEAR MAGNETIC
RESONANCE AND THEORETICAL CALCULATIONS 198 VICTOR J. HRUBY, OM PRAKASH,
WIESLAW KAZMIERSKI, CATHERINE GEHRIG, AND TERRY O. MATSUNAGA
PEPTIDOMIMETIC OPIOIDS*SYNTHESIS, SPECTROSCOPY, AND COMPUTER SIMULATIONS
218 MURRAY GOODMAN, ODILE E. SAID-NEJAD, EDUARD FELDER, DALE F. MIERKE,
TOSHIMASA YAMAZAKI, AND PETER W. SCHILLER MODIFIED SOLID-PHASE METHODS
FOR THE RAPID SYNTHESIS OF OPIOID PEPTIDES : 239 RICHARD A. HOUGHTEN,
JOHN M. OSTRESH, AND SUZANNE M. PRATT VI IRREVERSIBLE LIGANDS AS PROBES
FOR DRUG RECEPTORS 256 AMY HAUCK NEWMAN IMPORTANT COMPOUNDS IN THE
COCAINE CLASS: A SYNTHESIS OVERVIEW 284 F.I. CARROLL AND ANITA H. LEWIN
IMMUNOMODULATORY EFFECTS OF DRUGS OF ABUSE AND THE IMPORTANCE OF
STRUCTURE-LMMUNOMODULATORY ACTIVITY STUDIES 300 RAO S. RAPAKA AND
CHARLES P. HOIBERG FDA REGULATORY REQUIREMENTS FOR INVESTIGATIONAL NEW
DRUGS AND NEW DRUG APPLICATIONS: AN UPDATE 313 CHARLES P. HOIBERG AND
RAO S. RAPAKA LIST OF NIDA RESEARCH MONOGRAPHS 326 VII
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV005423366 |
callnumber-first | R - Medicine |
callnumber-label | RC566 |
callnumber-raw | RC566 RM315 |
callnumber-search | RC566 RM315 |
callnumber-sort | RC 3566 |
callnumber-subject | RC - Internal Medicine |
classification_rvk | CW 6940 |
ctrlnum | (OCoLC)24861441 (DE-599)BVBBV005423366 |
dewey-full | 615/.78 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.78 |
dewey-search | 615/.78 |
dewey-sort | 3615 278 |
dewey-tens | 610 - Medicine and health |
discipline | Psychologie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02330nam a2200577 cb4500</leader><controlfield tag="001">BV005423366</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20030310 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">920703s1991 xx ad|| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0160358515</subfield><subfield code="9">0-16-035851-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)24861441</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV005423366</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC566</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM315</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.78</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CW 6940</subfield><subfield code="0">(DE-625)19200:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Emerging technologies and new directions in drug abuse research</subfield><subfield code="c">eds.: Rao S. Rapaka ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rockville, MD</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VII, 335 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series</subfield><subfield code="v">112</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Troubles liés à une substance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug abuse</subfield><subfield code="x">Treatment</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Narcotics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Opioids</subfield><subfield code="x">Receptors</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychopharmacology</subfield><subfield code="x">Technological innovations</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Receptors, Opioid</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance-Related Disorders</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technology, Pharmaceutical</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Analyse</subfield><subfield code="0">(DE-588)4174139-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Molekulardesign</subfield><subfield code="0">(DE-588)4265444-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Analyse</subfield><subfield code="0">(DE-588)4174139-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Molekulardesign</subfield><subfield code="0">(DE-588)4265444-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rapaka, Rao S.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series</subfield><subfield code="v">112</subfield><subfield code="w">(DE-604)BV001902214</subfield><subfield code="9">112</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003390873&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003390873</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
geographic | USA |
geographic_facet | USA |
id | DE-604.BV005423366 |
illustrated | Illustrated |
indexdate | 2024-12-23T11:36:47Z |
institution | BVB |
isbn | 0160358515 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003390873 |
oclc_num | 24861441 |
open_access_boolean | |
owner | DE-12 DE-20 |
owner_facet | DE-12 DE-20 |
physical | VII, 335 S. Ill., graph. Darst. |
publishDate | 1991 |
publishDateSearch | 1991 |
publishDateSort | 1991 |
record_format | marc |
series | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |
series2 | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |
spellingShingle | Emerging technologies and new directions in drug abuse research National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series Troubles liés à une substance Drug abuse Treatment Research United States Narcotics Opioids Receptors Research United States Psychopharmacology Technological innovations United States Psychotropic Drugs Receptors, Opioid Substance-Related Disorders therapy Technology, Pharmaceutical Pharmazeutische Analyse (DE-588)4174139-0 gnd Molekulardesign (DE-588)4265444-0 gnd Halluzinogen (DE-588)4134941-6 gnd |
subject_GND | (DE-588)4174139-0 (DE-588)4265444-0 (DE-588)4134941-6 (DE-588)1071861417 |
title | Emerging technologies and new directions in drug abuse research |
title_auth | Emerging technologies and new directions in drug abuse research |
title_exact_search | Emerging technologies and new directions in drug abuse research |
title_full | Emerging technologies and new directions in drug abuse research eds.: Rao S. Rapaka ... |
title_fullStr | Emerging technologies and new directions in drug abuse research eds.: Rao S. Rapaka ... |
title_full_unstemmed | Emerging technologies and new directions in drug abuse research eds.: Rao S. Rapaka ... |
title_short | Emerging technologies and new directions in drug abuse research |
title_sort | emerging technologies and new directions in drug abuse research |
topic | Troubles liés à une substance Drug abuse Treatment Research United States Narcotics Opioids Receptors Research United States Psychopharmacology Technological innovations United States Psychotropic Drugs Receptors, Opioid Substance-Related Disorders therapy Technology, Pharmaceutical Pharmazeutische Analyse (DE-588)4174139-0 gnd Molekulardesign (DE-588)4265444-0 gnd Halluzinogen (DE-588)4134941-6 gnd |
topic_facet | Troubles liés à une substance Drug abuse Treatment Research United States Narcotics Opioids Receptors Research United States Psychopharmacology Technological innovations United States Psychotropic Drugs Receptors, Opioid Substance-Related Disorders therapy Technology, Pharmaceutical Pharmazeutische Analyse Molekulardesign Halluzinogen USA Konferenzschrift |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003390873&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV001902214 |
work_keys_str_mv | AT rapakaraos emergingtechnologiesandnewdirectionsindrugabuseresearch |